Eiger BioPharmaceuticals launch HDV campaign
Eiger BioPharmaceuticals' hepatitis delta campaign has been launched across the country. Read More »
Eiger BioPharmaceuticals' hepatitis delta campaign has been launched across the country. Read More »
Astellas Pharma and Pfizer's joint-supplemental New Drug Application that will see the update of the XTANDI capsules product label has been approved by the Food and Drug Administration. Read More »
Sunovion Pharmaceuticals' acquisition of Cynapsus Therapeutics has been finalized through Sunovion's subsidiary Sunovion CNS Development Canada. Read More »
Newron Pharmaceuticals, in association with its partners Zambon and US WorldMeds, has resubmitted the U.S. New Drug Application in September seeking a complete Class 2 response by the U.S. Food and Drug Administration for Xadago, also known by its generic name, safinamide. Read More »
Amgen's Phase 3 clinical trial to assess XGEVA compared to zoledronic acid has achieved its primary goal of proving to delay the time to the first skeletal-related event on-study for multiple myeloma patients. Read More »
CymaBay Therapeutics will present results of its Phase 2 proof-of-concept MBX-8025 clinical trial at the Annual Meeting of the American Association for the Study of Liver Diseases Nov. 11-15 in Boston. Read More »
Coupons offered by drug companies play a significant role in keeping prescription costs high, according to the co-author of a report that lays out solutions to fix problems with the system. Read More »
According to a new report released by the 2016 Generic Drug Savings and Access in the United States, generic prescription drugs generated 328 percent increase in annual savings since 2005. Read More »
Arrow Pharmaceuticals intends to give two presentations at The Liver Meeting 2016 on its investigational medicine designed to treat liver disease linked to alpha-1 antitrypsin deficiency, ARC-AAT. Read More »
Walgreens Boots Alliance and Rite Aid Corp. have issued a joint announcement stating that the two companies have mutually agreed to extend their merger agreement end date to Jan. 27. Read More »
CVS Health has launched CVS Pay across the country. Read More »
Mauna Kea Technologies' results of its CONTACT clinical trial have been presented at the United European Gastroenterology Week 2016 meeting. Read More »
Avella Specialty Pharmacy will acquire Advanced Pharma in a deal to be finalized in the fourth quarter of this year. Read More »
Perlara PBC, formerly known as Perlstein Lab PBC, has agreed to a drug discovery and development partnership with Novartis that will lead to the identification of new definitive therapeutics for the treatment of lysosomal storage disorders. Read More »
Walgreens has installed more than 500 safe medication disposal kiosks at pharmacy locations across 35 states and in Washington, D.C., reaching the goal it set out to achieve. Read More »
Spectrum Pharmaceuticals' Dr. Luigi Lenaz has been appointed the new lead director, a position recently created by the company. Read More »
Eli Lilly and Co. has launched an innovative new plan to increase the access of quality health care and to see the improvement of long-term health care for millions of individuals on a global scale. Read More »
According to a report by the 2016 NCPA Digest, which is sponsored by Cardinal Health, independent community pharmacies are an important to patients. Read More »
UnitedHealthcare's 2.4 million clients enrolled in its employer-sponsored health plans will soon be able to access Real Appeal, an online weight-loss program that is personalized, interactive and uses personal coaches and an internet television show that inspires individuals to be active, get healthy and lose weight. Read More »
UnitedHealthcare has unveiled its 2017 Medicare Advantage and Part D prescription drug plans, which include a new AARP MericareRx Walgreens plan that will be insured by UnitedHealthcare. Read More »